Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 7

1.

Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population.

Nicolaides KH, Syngelaki A, Ashoor G, Birdir C, Touzet G.

Am J Obstet Gynecol. 2012 Nov;207(5):374.e1-6. doi: 10.1016/j.ajog.2012.08.033. Epub 2012 Sep 19.

PMID:
23107079
[PubMed - indexed for MEDLINE]
2.

[Noninvasive prenatal diagnosis of trisomy 21, 18 and 13 using cell-free fetal DNA].

Gorzelnik K, Bijok J, Zimowski JG, Jakiel G, Roszkowski T.

Ginekol Pol. 2013 Aug;84(8):714-9. Review. Polish.

PMID:
24191506
[PubMed - indexed for MEDLINE]
3.

Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities.

Nicolaides KH.

Am J Obstet Gynecol. 2004 Jul;191(1):45-67. Review.

PMID:
15295343
[PubMed - indexed for MEDLINE]
4.

Maternal serum hCG and fetal nuchal translucency thickness for the prediction of fetal trisomies in the first trimester of pregnancy.

Brizot ML, Snijders RJ, Butler J, Bersinger NA, Nicolaides KH.

Br J Obstet Gynaecol. 1995 Feb;102(2):127-32. Review.

PMID:
7538782
[PubMed - indexed for MEDLINE]
5.

Cell-free fetal DNA and maternal serum analytes for monitoring embryonic and fetal status.

Simpson JL.

Fertil Steril. 2013 Mar 15;99(4):1124-34. doi: 10.1016/j.fertnstert.2013.02.012. Review.

PMID:
23499003
[PubMed - indexed for MEDLINE]
6.

Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies.

Langlois S, Duncan A.

J Obstet Gynaecol Can. 2011 Sep;33(9):955-60. Review.

PMID:
21923994
[PubMed - indexed for MEDLINE]
7.

One-stop clinic for assessment of risk of chromosomal defects at 12 weeks of gestation.

Nicolaides KH, Bindra R, Heath V, Cicero S.

J Matern Fetal Neonatal Med. 2002 Jul;12(1):9-18. Review.

PMID:
12422904
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk